• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].

作者信息

Xia Wenfang, Zhang Huanming, Pan Zhou, Li Guang, Zhou Qingshan, Hu Dan, Liu Yu

机构信息

Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.

出版信息

Int Immunopharmacol. 2023 Sep;122:110699. doi: 10.1016/j.intimp.2023.110699. Epub 2023 Jul 26.

DOI:10.1016/j.intimp.2023.110699
PMID:37500384
Abstract
摘要

相似文献

1
Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
Int Immunopharmacol. 2023 Sep;122:110699. doi: 10.1016/j.intimp.2023.110699. Epub 2023 Jul 26.
2
Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats.MRP4 抑制减轻大鼠脓毒症诱导的急性肺损伤。
Int Immunopharmacol. 2019 Jul;72:211-217. doi: 10.1016/j.intimp.2019.04.009. Epub 2019 Apr 14.
3
Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].对“(E)-2-甲氧基-4-(3-(4-甲氧基苯基)丙-1-烯-1-基)苯酚通过抑制STAT3磷酸化减轻脂多糖诱导的小鼠肝脏脓毒症中的炎症反应”的勘误[《国际免疫药理学》125(Part B)(2023)111124]
Int Immunopharmacol. 2024 Aug 20;137:112543. doi: 10.1016/j.intimp.2024.112543. Epub 2024 Jun 25.
4
Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Int Immunopharmacol. 2024 May 30;133:111787. doi: 10.1016/j.intimp.2024.111787. Epub 2024 Apr 18.
5
Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].《骨髓间充质干细胞来源的外泌体miR-127-5p通过抑制中性粒细胞胞外陷阱形成减轻脓毒症相关急性肺损伤》的勘误[《国际免疫药理学》123卷（2023年）110759页]
Int Immunopharmacol. 2023 Dec;125(Pt A):111076. doi: 10.1016/j.intimp.2023.111076. Epub 2023 Oct 20.
6
MiR-490 alleviates sepsis-induced acute lung injury by targeting MRP4 in new-born mice.miR-490 通过靶向新生小鼠的 MRP4 缓解脓毒症诱导的急性肺损伤。
Acta Biochim Pol. 2021 Mar 22;68(2):151-158. doi: 10.18388/abp.2020_5397.
7
Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].《Liproxstatin-1通过抑制铁死亡减轻LPS/IL-13诱导的小鼠支气管上皮细胞损伤和嗜中性粒细胞性哮喘》的勘误[《国际免疫药理学》109卷（2022年）108770页]
Int Immunopharmacol. 2023 Feb;115:109482. doi: 10.1016/j.intimp.2022.109482. Epub 2023 Jan 6.
8
Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].《硝普钠通过减轻氧化应激、炎症和细胞凋亡缓解乙酸诱导的大鼠结肠炎》的勘误 [《国际免疫药理学》99卷（2021年）108005页]
Int Immunopharmacol. 2022 Apr;105:108575. doi: 10.1016/j.intimp.2022.108575. Epub 2022 Feb 1.
9
Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].《右美托咪定中的中性粒细胞弹性蛋白酶减轻大鼠脓毒症相关肾损伤》的勘误 [《国际免疫药理学》122 (2023) 110441]
Int Immunopharmacol. 2024 Feb 15;128:111577. doi: 10.1016/j.intimp.2024.111577. Epub 2024 Jan 28.
10
Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].《“Pmepa1基因敲低通过p38丝裂原活化蛋白激酶/核苷酸结合寡聚化结构域样受体蛋白3轴减轻脊柱关节炎诱导的人骨髓间充质干细胞焦亡和成骨分化抑制”的勘误》[《国际免疫药理学》124(Part A)(2023)110843]
Int Immunopharmacol. 2023 Nov;124(Pt A):111013. doi: 10.1016/j.intimp.2023.111013. Epub 2023 Oct 6.